Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007342
Chunk: 22

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 22
---
 represent a smaller percentage of our total outstanding Ordinary Shares after any such issuance.

| 16 |

The following table sets forth
the amount of gross proceeds we may receive from the Selling Shareholder from our sale of Purchase Shares that we may issue and sell to
the Selling Shareholder from time to time under the Purchase Agreement assuming that all such Purchase Shares are sold at varying purchase
prices designated below:

| Assumed Purchase 
 Price            
 Per Share (1)    |         |     | Total Number of Purchase Shares to be 
 Issued if                             
 Full Purchase                         |            |     | Percentage of Outstanding                                   
 Ordinary Shares After                                       
 Giving Effect to the Issuance of Purchase Shares to Selling 
 Shareholder (2)                                             |       |     | Proceeds from the Sale        
 of the Purchase Shares to the 
 Selling                       
 Shareholder (3)               |            |
|:-----------------|--------:|:----|:--------------------------------------|-----------:|:----|:------------------------------------------------------------|:------|:----|:------------------------------|-----------:|
| $                |    1.00 |     |                                       | 35,000,000 |     |                                                             | 98.1% |     | $                             | 35,000,000 |
| $                | 4.13(4) |     |                                       |  8,474,576 |     |                                                             | 92.7% |     | $                             | 35,000,000 |
| $                |    5.00 |     |                                       |  7,000,000 |     |                                                             | 91.3% |     | $                             | 35,000,000 |
| $                |   10.00 |     |                                       |  3,500,000 |     |                                                             | 84.0% |     | $                             | 35,000,000 |
| $                |   15.00 |     |                                       |  2,333,333 |     |                                                             | 77.7% |     | $                             | 34,999,995 |

__________________

| (1) | The purchase price assumes a discount to the market price of our shares, in accordance with the terms 
 of the Purchase Agreement.                                                                            |

| (2) | The denominator is based on 6,685,918,922 Ordinary Shares outstanding as of January 15, 2025, adjusted                                          
 to include the issuance of the number of Purchase Shares